Placental cis-eQTL analysis identifies preeclampsia-dependent genetic regulation at promoters
- 1University of Helsinki
Abstract
Background: Preeclampsia (PE) is a hypertensive pregnancy disorder with contributions from both maternal and fetal genetic factors, but how both genomes regulate placental transcription remains incompletely understood. Results: We analyzed placental 5'-end RNA sequencing data from 59 pregnancies in the FINNPEC cohort and performed separate maternal and fetal cis-eQTL analyses using gene-level expression and promoter-level expression defined as Transcript Far 5' Ends (TFE). Genotype-by-PE interaction models were used to identify genetic effects that differ according to PE status. No gene-level interaction eQTLs remained significant after multiple-testing correction, although suggestive signals included LILRB2 in the maternal and LPCAT3 in the fetal analyses. In contrast, we identified two significant syntenic promoter-level interaction eQTLs: rs12504642-TFE61820 at the FHDC1 locus in the maternal analysis and rs1557150-TFE9032 at the PPIAP31 locus in the fetal analysis. Conclusion: These findings suggest that PE-dependent genetic interaction effects may be detectable at specific transcript promoter regions even when they are not captured at annotated gene levels.
Related
- Dynamic contrast enhanced MRI demonstrate altered placental perfusion in the STOX1A preeclampsia mouse model
- Fetal sex influences molecular regulation of human placental vascular development across gestation
- Integration of ATAC- and RNA-sequencing identifies chromatin and transcriptomic signatures in classical and non-classical zebrafish osteoblasts and indicates mechanisms of entpd5a regulation
- Systems genetics identifies ETS1 as a stress-dependent regulator of adipocyte insulin action and heme-iron homeostasis
- Context-dependent regulation of cytotoxic T lymphocytes by nuclear receptors
BibTeX
@misc{gunaydin2026placental,
title = {{Placental cis-eQTL analysis identifies preeclampsia-dependent genetic regulation at promoters}},
author = {G. Yazgeldi Gunaydin and J. Leinonen and S. Ezer and E. Kajantie and K. Kivinen and S. Heinonen and A. Pouta and FINNPEC Group and H. Laivuori and S. Wedenoja and J. Kere and S. Katayama},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.05.756656},
url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756656v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Placental cis-eQTL analysis identifies preeclampsia-dependent genetic regulation at promoters
AU - G. Yazgeldi Gunaydin
AU - J. Leinonen
AU - S. Ezer
AU - E. Kajantie
AU - K. Kivinen
AU - S. Heinonen
AU - A. Pouta
AU - FINNPEC Group
AU - H. Laivuori
AU - S. Wedenoja
AU - J. Kere
AU - S. Katayama
PY - 2026
DA - 2026/10/05
PB - bioRxiv
DO - 10.64898/2026.10.05.756656
UR - https://www.biorxiv.org/content/10.64898/2026.10.05.756656v1
AB - Background: Preeclampsia (PE) is a hypertensive pregnancy disorder with contributions from both maternal and fetal genetic factors, but how both genomes regulate placental transcription remains incompletely understood. Results: We analyzed placental 5'-end RNA sequencing data from 59 pregnancies in the FINNPEC cohort and performed separate maternal and fetal cis-eQTL analyses using gene-level expression and promoter-level expression defined as Transcript Far 5' Ends (TFE). Genotype-by-PE interaction models were used to identify genetic effects that differ according to PE status. No gene-level interaction eQTLs remained significant after multiple-testing correction, although suggestive signals included LILRB2 in the maternal and LPCAT3 in the fetal analyses. In contrast, we identified two significant syntenic promoter-level interaction eQTLs: rs12504642-TFE61820 at the FHDC1 locus in the maternal analysis and rs1557150-TFE9032 at the PPIAP31 locus in the fetal analysis. Conclusion: These findings suggest that PE-dependent genetic interaction effects may be detectable at specific transcript promoter regions even when they are not captured at annotated gene levels.
ER -